1. In this systematic review, ten studies reported risk reclassification of prostate cancer with genome classifier testing, with wide variation across different genome classifier tests. 2. Treatment ...
1. The use of thymosin α1 in adult patients with sepsis was not associated with a reduction in all cause 28 day mortality. Evidence Rating Level: 1 (Excellent) Thymosin α1 is an immodulatory therapy ...
Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term benefits by reducing the rate of exacerbations over a 24-week period. In ...